farmaco semaglutide Study reveals oral 50 mg as promising treatment for obesity in adults: the Lancet report Compounded Semaglutide

The delicious, naturally flavored (*strawberry) drink supports overall gut health and energy levels

Issue 42 of The Altascientist explores GLP-1 receptor agonist drug development, covering preclinical models, bioanalytical assays, clinical study design, and manufacturing

As cash-pay patients search for affordable compounded GLP-1 access in 2026, Direct Meds stands out for its active LegitScript certification, consistent...

The authors discuss the preclinical literature and emerging clinical evidence that support the rationale for investigating the use of glucagon-like peptide-1 receptor agonists to prevent and treat several neurodegenerative diseases of aging, with a focus on Alzheimers disease.

Meet your protein needs while on GLP-1 RAs.